Join the club for FREE to access the whole archive and other member benefits.

Robert Chiesa

Consultant in paediatric bone marrow transplantation at Great Ormond Street Hospital

Consultant in paediatric bone marrow transplantation at Great Ormond Street Hospital, with expertise in managing children with malignant and non-malignant disorders (immunodeficiencies/inborn errors metabolism).

Principal Investigator in phase II study on Pharmacokinetics of Treosulfan.

Principal Investigator in phase I study on Radio-immunotherapy with Yttrium-90.

Chief Investigator in phase 2 study on Radio-immunotherapy with Yttrium-90 in children with high risk leukaemia.

Principal Investigator in phase II study on use of Defibrotide in BMT.

Principal Investigator in phase II study on BMT in X-ALD.

Co-chief investigator in a phase 2 study on stem cell gene therapy in cerebral ALD.

Principal Investigator in phase 2 study on use of Nomacopan in paediatric TMA.

Principal Investigator in retrospective European study on BMT in CGD.

Immune reconstitution after umbilical cord blood transplantation.

Pharmacokinetics of Busulfan.

Co-investigator in phase I study on use of autologous CD19/22CAR-T cell therapy in ALL.

Co-investigator in phase II study on use of allo CD19 CAR T cell therapy in ALL

Lead on national anti-fungal guidelines in paediatric BMT

Visit website: https://www.gosh.ae/consultants/dr-robert-chiesa

 robert-chiesa-595589b6

See also: Health Organisation Great Ormond Street Hospital (GOSH) - Children's hospital for special care.

Details last updated 24-Jan-2023

Robert Chiesa News

Therapeutic applications of base editing clears girl's leukemia

BBC - 11-Dec-2022

Base editing can soon be a part in taking control of our genomes to fight genetic diseases

Read more...